
After a massive restructuring at the company last year, the new CEO of Takeda's Danish operations, Roland Kurney, is looking for new employees, Dagens Pharma reports.
Last year, Takeda sold its OTC business, which consisted of around 130 products, to Danish firm Orifarm for DKK 4.3bn (USD 669m). This resulted in more than 600 employees following the products to Orifarm.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app